[Possible consequences of subclinical hypothyroidism].

Acta medica Austriaca Pub Date : 2003-01-01
M Weissel
{"title":"[Possible consequences of subclinical hypothyroidism].","authors":"M Weissel","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Subclinical hypothyroidism is defined as elevated TSH in the presence of normal free T4 and T3 levels. This review discusses the following questions concerning subclinical hypothyroidism that have not been solved yet: 1) does elevated TSH always mean failure of the thyroid gland? 2) Do patients with subclinical hypothyroidism always develop overt hypothyroidism? 3) Are they symptomatic? 4) Does treatment with L-Thyroxine cure these symptoms,--if they exist? Summarizing the results of the literature one can give the following answers: 1) Elevated TSH with normal free T4 can but does not necessarily mean thyroid failure. 2) Patients with positive thyroid antibodies and especially with TSH levels above 10 mU/l are at high risk to develop overt hypothyroidism. 3) Typical symptoms (thyroid-specific, cardiovascular, neurological and psychiatric and finally alterations of risk factors for atherosclerosis) seem to occur in a greatly varying percentage of patients--some of the described symptoms are of questionable clinical importance. 4) Some of the symptoms, especially the cardiovascular, seem to be treatable by L-T4, whereas others like most of the changes in lipid metabolism can not be influenced by normalization of the TSH levels. In conclusion, screening for TSH and free T4 seems to be justified in elderly women, where the prevalence of the disease is approximately 20%. However, treatment of \"symptoms\" of subclinical hypothyroidism like elevated cholesterol levels or depression should be done only in patients with a TSH > 10 mU/l and there only with great caution in order to avoid unnecessary overdosage with the danger of eliciting atrial fibrillation.</p>","PeriodicalId":6945,"journal":{"name":"Acta medica Austriaca","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica Austriaca","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Subclinical hypothyroidism is defined as elevated TSH in the presence of normal free T4 and T3 levels. This review discusses the following questions concerning subclinical hypothyroidism that have not been solved yet: 1) does elevated TSH always mean failure of the thyroid gland? 2) Do patients with subclinical hypothyroidism always develop overt hypothyroidism? 3) Are they symptomatic? 4) Does treatment with L-Thyroxine cure these symptoms,--if they exist? Summarizing the results of the literature one can give the following answers: 1) Elevated TSH with normal free T4 can but does not necessarily mean thyroid failure. 2) Patients with positive thyroid antibodies and especially with TSH levels above 10 mU/l are at high risk to develop overt hypothyroidism. 3) Typical symptoms (thyroid-specific, cardiovascular, neurological and psychiatric and finally alterations of risk factors for atherosclerosis) seem to occur in a greatly varying percentage of patients--some of the described symptoms are of questionable clinical importance. 4) Some of the symptoms, especially the cardiovascular, seem to be treatable by L-T4, whereas others like most of the changes in lipid metabolism can not be influenced by normalization of the TSH levels. In conclusion, screening for TSH and free T4 seems to be justified in elderly women, where the prevalence of the disease is approximately 20%. However, treatment of "symptoms" of subclinical hypothyroidism like elevated cholesterol levels or depression should be done only in patients with a TSH > 10 mU/l and there only with great caution in order to avoid unnecessary overdosage with the danger of eliciting atrial fibrillation.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[亚临床甲状腺功能减退的可能后果]。
亚临床甲状腺功能减退被定义为在游离T4和T3水平正常的情况下TSH升高。本文就亚临床甲状腺功能减退尚未解决的以下问题进行讨论:1)TSH升高是否一定意味着甲状腺功能衰竭?2)亚临床甲状腺功能减退患者是否总有明显的甲状腺功能减退?3)有症状吗?4)如果存在这些症状,用l -甲状腺素治疗能治愈吗?总结文献的结果,可以给出以下答案:1)TSH升高而游离T4正常可能但并不一定意味着甲状腺功能衰竭。2)甲状腺抗体阳性,特别是TSH水平高于10 mU/l的患者发生显性甲状腺功能减退的风险较高。3)典型症状(甲状腺特异性、心血管、神经和精神以及动脉粥样硬化危险因素的最终改变)似乎在很大程度上不同的患者中出现——所描述的一些症状的临床重要性值得怀疑。4)一些症状,特别是心血管症状,似乎可以通过L-T4治疗,而其他症状,如大多数脂质代谢的变化,不能受TSH水平正常化的影响。总之,在老年妇女中进行TSH和游离T4筛查似乎是合理的,因为老年妇女的发病率约为20%。然而,治疗亚临床甲状腺功能减退的“症状”,如胆固醇水平升高或抑郁,只应在TSH > 10 mU/l的患者中进行,并且必须非常谨慎,以避免不必要的过量使用,以免引起房颤的危险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
ESC Congress 2003 – European Society of Cardiology EANM ’03 – Annual Congress of the European Association of Nuclear Medicine Editorial: Stellungnahme zum Marktrückzug von Cerivastatin Therapie der endokrinen Orbitopathie mit Somatostatin-Analoga bei Patienten mit positivem Octreo-Scan The Influence of Obesity on the Frequency and Distribution of Medication Der Einfluß der Adipositas auf die Häufigkeit und Verteilung der Medikation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1